Process evaluation of a behaviour change approach to improving clinical practice for detecting hereditary cancer.
Attitude of Health Personnel
Australia
Colorectal Neoplasms, Hereditary Nonpolyposis
/ diagnosis
Delivery of Health Care
Health Services Research
Hospitals, Public
Humans
Interviews as Topic
Patient Care Team
/ organization & administration
Process Assessment, Health Care
Referral and Consultation
Retrospective Studies
Hereditary cancer
Implementation
Process evaluation
Theoretical domains framework implementation
Theory
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
20 Mar 2019
20 Mar 2019
Historique:
received:
13
11
2018
accepted:
01
03
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
21
5
2019
Statut:
epublish
Résumé
This retrospective process evaluation reports on the application of a 1-year implementation program to increase identification and management of patients at high risk of a hereditary cancer syndrome. The project used the Theoretical Domains Framework Implementation (TDFI) approach, a promising implementation methodology, used successfully in the United Kingdom to address patient safety issues. This Australian project run at two large public hospitals aimed to increase referrals of patients flagged as being at risk of Lynch syndrome on the basis of a screening test to genetic services. At the end of the project, the pathologists' processes had changed, but the referral rate remained inconsistent and low. Semi-structured interviews explored participants' perceptions of the TDFI approach and Health services researchers wrote structured reflections. Interview transcripts and reflections were coded initially against implementation outcomes for the various TDFI approach activities: acceptability, appropriateness, feasibility, value for time cost, and adoption. On a second pass, themes were coded around challenges to the approach. Interviews were held with nine key project participants including pathologists, oncologists, surgeons, genetic counsellors and an administrative officer. Two health services researchers wrote structured reflections. The first of two major themes was 'Theory-related challenges', with subthemes of accessibility of theory underpinning the TDFI, commitment to that theory-based approach, and the problem of complexity. The second theme was 'Practical challenges' with subthemes of stakeholder management, navigating the system, and perceptions of the problem. Health services researchers reflected on the benefits of bridging professional divides and facilitating collective learning and problem solving, but noted frustrations around clinicians' time constraints that led to sparse interactions with the team, and lack of authority to effect change themselves. Mixed success of adoption as an outcome was attributed to the complexity and highly nuanced nature of the setting. This made identifying the target behaviour, a key step in the TDFI approach, challenging. Introduced changes in the screening process led to new, unexpected issues yet to be addressed. Strategies to address challenges are presented, including using an internal facilitator with a focus on applying a theory-based implementation approach.
Sections du résumé
BACKGROUND
BACKGROUND
This retrospective process evaluation reports on the application of a 1-year implementation program to increase identification and management of patients at high risk of a hereditary cancer syndrome. The project used the Theoretical Domains Framework Implementation (TDFI) approach, a promising implementation methodology, used successfully in the United Kingdom to address patient safety issues. This Australian project run at two large public hospitals aimed to increase referrals of patients flagged as being at risk of Lynch syndrome on the basis of a screening test to genetic services. At the end of the project, the pathologists' processes had changed, but the referral rate remained inconsistent and low.
METHODS
METHODS
Semi-structured interviews explored participants' perceptions of the TDFI approach and Health services researchers wrote structured reflections. Interview transcripts and reflections were coded initially against implementation outcomes for the various TDFI approach activities: acceptability, appropriateness, feasibility, value for time cost, and adoption. On a second pass, themes were coded around challenges to the approach.
RESULTS
RESULTS
Interviews were held with nine key project participants including pathologists, oncologists, surgeons, genetic counsellors and an administrative officer. Two health services researchers wrote structured reflections. The first of two major themes was 'Theory-related challenges', with subthemes of accessibility of theory underpinning the TDFI, commitment to that theory-based approach, and the problem of complexity. The second theme was 'Practical challenges' with subthemes of stakeholder management, navigating the system, and perceptions of the problem. Health services researchers reflected on the benefits of bridging professional divides and facilitating collective learning and problem solving, but noted frustrations around clinicians' time constraints that led to sparse interactions with the team, and lack of authority to effect change themselves.
CONCLUSIONS
CONCLUSIONS
Mixed success of adoption as an outcome was attributed to the complexity and highly nuanced nature of the setting. This made identifying the target behaviour, a key step in the TDFI approach, challenging. Introduced changes in the screening process led to new, unexpected issues yet to be addressed. Strategies to address challenges are presented, including using an internal facilitator with a focus on applying a theory-based implementation approach.
Identifiants
pubmed: 30894169
doi: 10.1186/s12913-019-3985-5
pii: 10.1186/s12913-019-3985-5
pmc: PMC6425681
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
180Subventions
Organisme : Cancer Institute NSW
ID : 2016 Premier's Award for Excellence in Translational Cancer Research
Références
Acad Manage J. 1981 Dec;24(4):689-713
pubmed: 10253688
BMJ. 2001 Sep 15;323(7313):625-8
pubmed: 11557716
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
Milbank Q. 2007;85(1):93-138
pubmed: 17319808
Health Psychol. 2008 May;27(3):379-87
pubmed: 18624603
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Adm Policy Ment Health. 2009 Jan;36(1):24-34
pubmed: 19104929
Intern Med J. 2009 Jun;39(6):389-400
pubmed: 19580618
Implement Sci. 2009 Jul 16;4:40
pubmed: 19607700
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMJ Qual Saf. 2011 May;20(5):453-9
pubmed: 21317181
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
BMJ. 2011 Jun 21;342:d3447
pubmed: 21693533
Lancet. 2013 Feb 2;381(9864):419-21
pubmed: 23374480
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMC Health Serv Res. 2013 Apr 30;13:158
pubmed: 23631517
J Clin Oncol. 2013 Jul 10;31(20):2554-62
pubmed: 23733757
Implement Sci. 2013 Jul 29;8:81
pubmed: 23895628
J Epidemiol Community Health. 2014 Feb;68(2):101-2
pubmed: 24022816
Implement Sci. 2013 Oct 16;8:123
pubmed: 24131864
Br J Surg. 2013 Dec;100(13):1719-31
pubmed: 24227356
Int J Qual Health Care. 2014 Jun;26(3):321-9
pubmed: 24796491
Implement Sci. 2014 May 01;9:51
pubmed: 24885553
J Clin Oncol. 2015 Jan 10;33(2):209-17
pubmed: 25452455
BMC Health Serv Res. 2014 Dec 21;14:648
pubmed: 25528580
BMJ Qual Saf. 2015 Mar;24(3):228-38
pubmed: 25616279
BMC Health Serv Res. 2016 Mar 12;16:89
pubmed: 26969429
Lancet. 2016 Aug 6;388(10044):547-8
pubmed: 27511773
Implement Sci. 2016 Sep 20;11(1):127
pubmed: 27647152
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
BMC Health Serv Res. 2017 Aug 14;17(1):558
pubmed: 28806903
Drug Discov Today. 2018 Jan;23(1):187-195
pubmed: 29129805
Med J Aust. 2018 Mar 5;208(4):152-154
pubmed: 29490214
BMC Med. 2018 Apr 30;16(1):63
pubmed: 29706132
BMC Health Serv Res. 2018 Nov 28;18(1):904
pubmed: 30486812